Logo preloader

DEFEAT CANCER

NETRIS Pharma is dedicated to defeat cancer through novel and unique approach targeting Dependence Receptors
visuel information

A Unique Environment to Develop Innovative Therapeutics

NETRIS Pharma is the first spin-off of Centre Léon Bérard and the Cancer Research Center of Lyon – CRCL – (Lyon, France) and benefits from the exceptional environment of this world’s renowned comprehensive center dedicated to cancer care, education and research.

IMG_0243 IMG_0456
visuel information

Innovative Therapeutic Approach

By developing therapeutic products targeting a yet unexplored mechanism of cancer resistance, we offer patients novel therapeutic solutions alleviating resistance to chemotherapy, targeted therapy and immunotherapy.

IMG_0484 IMG_0382
Generated with Avocode.Picto-ampoule-cadenasRectanglePicto-ampoule-cadenasShapeShapePath
A Strategic Focus on Intellectual Property Rights

As the world pioneer and leader biotech company targeting ligands of Dependence Receptors, NETRIS Pharma has built and is periodically reinforcing a unique portfolio of worldwide exclusive rights and patents on all key elements of its approach and activity.

Our partners

NETRIS Pharma has grown from inception with the full support of Research, Clinical and Corporate partners.

Clinical
Corporate
Research
Logo-centre-leon-bernard
Logo-HCL
Logo-CHU-Grenoble-Alpes
Logo-Arcagy_gineco
Logo-bpi-france
Logo-région-Auvergne-Rhône-Alpes
Logo-Lyon-Biopole-AURA
Logo-union-européenne
Logo-CLARA
Logo-Inserm
Logo-Université-Lyon-1
anr-logo
Logo-CNRS
Logo-Université-Lyon
CRCL